CHRISTINA HANSON: Open Payments
NPI 1336351907 · LONE TREE, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200,761 in 266 payments from 20 companies in 2025. Trend: 2023 $35,524 · 2024 $97,729 · 2025 $200,761
Speaker / faculty: $149,502Travel & lodging: $26,971Consulting: $17,512Food & beverage: $6,776
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 48 | $99,429 |
| Regeneron Healthcare Solutions, Inc. | 43 | $20,469 |
| Ardelyx, Inc. | 36 | $18,520 |
| Novo Nordisk Inc | 15 | $15,304 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 36 | $13,419 |
| Ipsen Biopharmaceuticals, Inc | 21 | $12,638 |
| Madrigal Pharmaceuticals | 21 | $8,467 |
| Phathom Pharmaceuticals, Inc. | 5 | $4,131 |
| Janssen Biotech, Inc. | 11 | $2,863 |
| GlaxoSmithKline, LLC. | 3 | $2,150 |
Products named: DUPIXENT, IBSRELA, XIFAXAN, IQIRVO, REZDIFFRA, Wegovy, VOQUEZNA, TREMFYA.
Industry payments across CO — which companies pay providers there.
